Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection.
Saved in:
| Title: | Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection. |
|---|---|
| Authors: | Younossi, Zobair M.1,2 zobair.younossi@inova.org, Stepanova, Maria3, Henry, Linda3, Han, Kwang‐Hyub4, Ahn, Sang Hoon4, Lim, Young‐Suk5, Chuang, Wan‐Long6, Kao, Jia‐Horng7, Nguyen, Kinh V.8, Lai, Ching Lung9, Chan, Henry Lik‐Yuen10, Wei, Lai11 |
| Source: | Journal of Viral Hepatitis. Dec2018, Vol. 25 Issue 12, p1429-1437. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13520504 |
|---|---|
| DOI: | 10.1111/jvh.12965 |
